Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

Winfried Randerath; Johan Verbraecken; Stefan Andreas; Michael Arzt; Konrad E Bloch; Thomas Brack; Bertien Buyse; Wilfried De Backer; Danny Joel Eckert; Ludger Grote; Lars Hagmeyer; Jan Hedner; Poul Jennum; Maria Teresa La Rovere; Carla Miltz; Walter T McNicholas; Josep Montserrat; Matthew Naughton; Jean-Louis Pepin; Dirk Pevernagie; Bernd Sanner; Dries Testelmans; Thomy Tonia; Bart Vrijsen; Peter Wijkstra; Patrick Levy

doi:10.1183/13993003.00959-2016

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

Winfried Randerath, Johan Verbraecken, Stefan Andreas, Michael Arzt, Konrad E Bloch, Thomas Brack, Bertien Buyse, Wilfried De Backer, Danny Joel Eckert, Ludger Grote, Lars Hagmeyer, Jan Hedner, Poul Jennum, Maria Teresa La Rovere, Carla Miltz, Walter T McNicholas, Josep Montserrat, Matthew Naughton, Jean-Louis Pepin, Dirk PevernagieBernd Sanner, Dries Testelmans, Thomy Tonia, Bart Vrijsen, Peter Wijkstra, Patrick Levy

Institut for Klinisk Medicin

105 Citationer (Scopus)

Abstract

The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a "marker" of disease severity or a "mediator" of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.

Originalsprog	Engelsk
Artikelnummer	1600959
Tidsskrift	European Respiratory Journal
Vol/bind	49
Udgave nummer	1
Antal sider	28
ISSN	0903-1936
DOI	https://doi.org/10.1183/13993003.00959-2016
Status	Udgivet - 1 jan. 2017

Adgang til dokumentet

10.1183/13993003.00959-2016

1600959.full.pdfForlagets udgivne version, 539 KB

Citationsformater

Randerath, W., Verbraecken, J., Andreas, S., Arzt, M., Bloch, K. E., Brack, T., Buyse, B., De Backer, W., Eckert, D. J., Grote, L., Hagmeyer, L., Hedner, J., Jennum, P., La Rovere, M. T., Miltz, C., McNicholas, W. T., Montserrat, J., Naughton, M., Pepin, J.-L., ... Levy, P. (2017). Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. European Respiratory Journal, 49(1), Artikel 1600959. https://doi.org/10.1183/13993003.00959-2016

Randerath, W, Verbraecken, J, Andreas, S, Arzt, M, Bloch, KE, Brack, T, Buyse, B, De Backer, W, Eckert, DJ, Grote, L, Hagmeyer, L, Hedner, J, Jennum, P, La Rovere, MT, Miltz, C, McNicholas, WT, Montserrat, J, Naughton, M, Pepin, J-L, Pevernagie, D, Sanner, B, Testelmans, D, Tonia, T, Vrijsen, B, Wijkstra, P & Levy, P 2017, 'Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep', European Respiratory Journal, bind 49, nr. 1, 1600959. https://doi.org/10.1183/13993003.00959-2016

@article{646412c95bb141538162b916e1f43d5d,

title = "Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep",

abstract = "The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a {"}marker{"} of disease severity or a {"}mediator{"} of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.",

keywords = "Advisory Committees, Analgesics, Opioid/therapeutic use, Europe, Humans, Hypoventilation/etiology, Polysomnography, Positive-Pressure Respiration, Practice Guidelines as Topic, Review Literature as Topic, Sleep, Sleep Apnea, Central/diagnosis",

author = "Winfried Randerath and Johan Verbraecken and Stefan Andreas and Michael Arzt and Bloch, {Konrad E} and Thomas Brack and Bertien Buyse and {De Backer}, Wilfried and Eckert, {Danny Joel} and Ludger Grote and Lars Hagmeyer and Jan Hedner and Poul Jennum and {La Rovere}, {Maria Teresa} and Carla Miltz and McNicholas, {Walter T} and Josep Montserrat and Matthew Naughton and Jean-Louis Pepin and Dirk Pevernagie and Bernd Sanner and Dries Testelmans and Thomy Tonia and Bart Vrijsen and Peter Wijkstra and Patrick Levy",

note = "Copyright {\textcopyright}ERS 2017.",

year = "2017",

month = jan,

day = "1",

doi = "10.1183/13993003.00959-2016",

language = "English",

volume = "49",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "1",

}

TY - JOUR

T1 - Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

AU - Randerath, Winfried

AU - Verbraecken, Johan

AU - Andreas, Stefan

AU - Arzt, Michael

AU - Bloch, Konrad E

AU - Brack, Thomas

AU - Buyse, Bertien

AU - De Backer, Wilfried

AU - Eckert, Danny Joel

AU - Grote, Ludger

AU - Hagmeyer, Lars

AU - Hedner, Jan

AU - Jennum, Poul

AU - La Rovere, Maria Teresa

AU - Miltz, Carla

AU - McNicholas, Walter T

AU - Montserrat, Josep

AU - Naughton, Matthew

AU - Pepin, Jean-Louis

AU - Pevernagie, Dirk

AU - Sanner, Bernd

AU - Testelmans, Dries

AU - Tonia, Thomy

AU - Vrijsen, Bart

AU - Wijkstra, Peter

AU - Levy, Patrick

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a "marker" of disease severity or a "mediator" of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.

AB - The complexity of central breathing disturbances during sleep has become increasingly obvious. They present as central sleep apnoeas (CSAs) and hypopnoeas, periodic breathing with apnoeas, or irregular breathing in patients with cardiovascular, other internal or neurological disorders, and can emerge under positive airway pressure treatment or opioid use, or at high altitude. As yet, there is insufficient knowledge on the clinical features, pathophysiological background and consecutive algorithms for stepped-care treatment. Most recently, it has been discussed intensively if CSA in heart failure is a "marker" of disease severity or a "mediator" of disease progression, and if and which type of positive airway pressure therapy is indicated. In addition, disturbances of respiratory drive or the translation of central impulses may result in hypoventilation, associated with cerebral or neuromuscular diseases, or severe diseases of lung or thorax. These statements report the results of an European Respiratory Society Task Force addressing actual diagnostic and therapeutic standards. The statements are based on a systematic review of the literature and a systematic two-step decision process. Although the Task Force does not make recommendations, it describes its current practice of treatment of CSA in heart failure and hypoventilation.

KW - Advisory Committees

KW - Analgesics, Opioid/therapeutic use

KW - Europe

KW - Humans

KW - Hypoventilation/etiology

KW - Polysomnography

KW - Positive-Pressure Respiration

KW - Practice Guidelines as Topic

KW - Review Literature as Topic

KW - Sleep

KW - Sleep Apnea, Central/diagnosis

U2 - 10.1183/13993003.00959-2016

DO - 10.1183/13993003.00959-2016

M3 - Journal article

C2 - 27920092

SN - 0903-1936

VL - 49

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - 1

M1 - 1600959

ER -

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater